PHARMACOECONOMICS
Scope & Guideline
Exploring the intersection of economics and pharmaceutical care.
Introduction
Aims and Scopes
- Economic Evaluation of Health Technologies:
The journal publishes studies that evaluate the cost-effectiveness of various health interventions, including pharmaceuticals, medical devices, and healthcare services, using methodologies such as cost-utility analysis, cost-effectiveness analysis, and budget impact analysis. - Modeling Approaches in Health Economics:
A significant focus is on the development and application of various modeling techniques, including Markov models, discrete event simulation, and probabilistic modeling, to assess long-term outcomes and economic impacts of health interventions. - Patient-Centered Outcomes and Quality of Life:
Research related to the measurement of health-related quality of life (HRQoL) and patient preferences is prominent. This includes studies on utility measures like EQ-5D and their application in economic evaluations. - Real-World Evidence and Data Utilization:
The journal encourages the use of real-world data to inform economic evaluations and policy decisions, emphasizing the relevance of real-world evidence in assessing the economic impact of interventions. - Interdisciplinary Approaches to Health Economics:
It promotes an interdisciplinary perspective, integrating insights from clinical research, epidemiology, health policy, and behavioral economics to enhance the depth and applicability of economic evaluations.
Trending and Emerging
- Value-Based Healthcare and Pricing Models:
There is a growing emphasis on value-based healthcare frameworks that assess the value of interventions in terms of outcomes relative to costs. This trend reflects the shift towards outcome-oriented pricing models in the healthcare industry. - Equity and Social Determinants of Health:
Research addressing health equity and the social determinants of health is gaining traction, emphasizing the importance of considering how economic evaluations can impact diverse populations and promote equitable healthcare access. - Integration of Real-World Data:
The use of real-world data in economic evaluations is on the rise, highlighting the importance of incorporating actual patient outcomes and resource utilization into cost-effectiveness analyses. - Patient and Stakeholder Engagement:
There is an increasing focus on involving patients and stakeholders in the economic evaluation process to better capture preferences and improve the relevance of health technologies to end-users. - Innovative Methodological Approaches:
Emerging methodologies, such as machine learning and advanced statistical techniques, are being applied to economic evaluations, enhancing the robustness and precision of analyses in complex healthcare environments.
Declining or Waning
- Traditional Cost-Effectiveness Analysis:
There is a noticeable reduction in studies solely focused on traditional cost-effectiveness analysis without considering broader implications, such as equity or long-term societal impacts. This indicates a shift towards more comprehensive evaluation frameworks. - Pharmacoeconomic Evaluations of Older Therapies:
Research on older therapies appears to be declining as newer, more innovative treatments emerge. The focus is shifting towards assessing the economic impact of cutting-edge therapies and technologies rather than established treatments. - Narrowly Focused Economic Models:
The journal has seen fewer publications that rely on narrowly focused economic models with limited scope. There is now a trend towards more complex models that account for a variety of factors, including patient heterogeneity and real-world complexities. - Sole Emphasis on Cost Minimization:
Papers that primarily focus on cost minimization strategies without addressing the broader implications for health outcomes and quality of life are becoming less frequent, as the field moves towards more holistic evaluations. - Regional Studies with Limited Generalizability:
There is a waning interest in studies that focus exclusively on localized economic evaluations without consideration for broader applicability or generalizability to other settings or populations.
Similar Journals
Journal of Comparative Effectiveness Research
Unlocking the potential of healthcare interventions.Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.
Expert Review of Pharmacoeconomics & Outcomes Research
Unlocking the Value of Pharmacoeconomics for Healthcare ProgressExpert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.
Health Economics Review
Advancing insights in health economics and policy.Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.
Farmeconomia-Health Economics and Therapeutic Pathways
Connecting research and policy for effective healthcare solutions.Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.
CLINICAL THERAPEUTICS
Pioneering the future of drug development and clinical practice.Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.
Pharmacoeconomics-Open
Championing Open Access for Global Health SolutionsPharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.
Gesundheitsoekonomie und Qualitaetsmanagement
Navigating the Complexities of Healthcare EconomicsGesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.
Global & Regional Health Technology Assessment
Fostering interdisciplinary dialogue for health advancement.Global & Regional Health Technology Assessment (ISSN: 2284-2403; E-ISSN: 2283-5733) is an esteemed open-access journal published by ABOUTSCIENCE SRL, dedicated to the dissemination of research in the field of health technology assessment on a global and regional scale. Since its inception in 2014, this journal has focused on the critical evaluation of health technologies, providing invaluable insights into their efficacy, cost-effectiveness, and impact on healthcare systems. With an increasing emphasis on public health and policy implications, the journal encourages interdisciplinary research that bridges gaps between technological innovations and health outcomes. Despite its relatively recent establishment, it has made significant inroads with Scopus rankings reflecting the growing importance of health technology assessment in global health discourse. The journal welcomes contributions from researchers, professionals, and students, inviting them to engage in discussions that shape the future of health technology, with the aim of informing stakeholders and policymakers worldwide.
Cost Effectiveness and Resource Allocation
Elevating Health Economics for a Sustainable FutureCost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.
Journal of Health Economics and Outcomes Research
Exploring the economics of health for a better tomorrow.Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.